Recent Updates
Recently added Catalysts
ILMN Positive Sentiment Score: 75/100

Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming...

Key Takeaway: Illumina, Inc. (NASDAQ: ILMN) announced an upcoming investor session at the Advances in Genome Biology and Technology (AGBT) conference, scheduled for February 25, 2025. The session will include a fireside chat featuring CEO Jacob Thaysen, CFO Ankur Dhingra, and CTO Steve Barnard. Interested parties can access the live webcast via Illumina's website. A replay of the event will also be available online for at least 30 days after the session.

Market Sentiment Analysis

POSITIVE FACTORS

  • Illumina is actively engaging with investors at the AGBT conference.
  • The event features high-profile executives, highlighting the company's leadership.
  • Illumina's commitment to innovation strengthens its position in the genomic industry.

Full Press Release Details

SAN DIEGO , Feb. 18, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN ) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session at the AGBT conference.
The investor fireside chat will begin at 8:00am Pacific Time ( 11:00am Eastern Time ) on Tuesday, February 25, 2025 and will feature Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer).
Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link – ( https://illumina-agbt-investor-session-feb-2025.open-exchange.net/ ) To ensure timely connection, please join at least ten minutes before the scheduled start of the session.
A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter) , Facebook , LinkedIn , Instagram , TikTok , and YouTube .
Investors: Salli Schwartz +1.858.291.6421 [email protected]
Media: Bonny Fowler +1.740.641.5579 [email protected]
SOURCE Illumina, Inc.

21 %

Frequently Asked Questions

When is Illumina's investor session at the AGBT conference?

The investor session will be on February 25, 2025, at 8:00 AM PT.

Who will speak at the investor fireside chat?

CEO Jacob Thaysen, CFO Ankur Dhingra, and CTO Steve Barnard will speak.

How can I access the live webcast of the event?

The webcast can be accessed on Illumina's Investor Info section or via a specific link.

Will there be a replay of the investor session available?

Yes, a replay will be available on Illumina's website for at least 30 days.

What industries does Illumina serve?

Illumina serves life sciences, oncology, reproductive health, agriculture, and more.

Last updated: Feb 18, 2025